Overview
The aim of the study is to evaluate the effectiveness of the under-mattress monitoring device to aid in the titration process of a mandibular advancement device (MAD) for the management of obstructive sleep apnea (OSA). A secondary aim is to evaluate changes in subjective OSA symptoms and patient's satisfaction with MAD. A third aim is to analyze if there are differences between the sleep parameters recorded by the under-mattress monitor between responders and non-responders to MAD therapy.
Eligibility
Inclusion Criteria:
- Diagnosis of Obstructive Sleep Apnea demonstrated with a sleep study polysomnography or home sleep study (PSG or HSAT), manually scored by a sleep physician according to the 2017 American Academy of Sleep medicine scoring guidelines.
- Willingness to commute to the OFP clinic every 2 weeks during MAD titration period.
- Consent to partake in the study.
Exclusion Criteria:
- Diagnosis of central or mixed sleep apnea.
- Neurocognitive disease.
- Concomitant therapy with PAP therapy.
- Allergic to the appliance material (Polyamide 12).
- Presence of active dental decay, ill-fitting dental restorations, or crown to root ratio unfavorable.
- Inadequate English language comprehension.
- Lack of coordination or dexterity to insert/remove the MAD intraorally.
- Inability to tolerate digital dental impressions.
- Patients with concomitant diagnosed sleep disorders, including narcolepsy, restless leg syndrome, rapid eye movement sleep behavior disorder).